Sikandar Shaikh1,2,3
1Department of Radiodiagnosis, Shadan Institute of Medical Sciences.. Hyderabad. India, Hyderabad, India, 2Department of Radiodiagnosis, Kasturba Medical College, Manipal, India, 3Department of Biomedical Engineering, Indian Institute of Technology, Hyderabad, India
Synopsis
MRI is the important modality for the evaluation of
the Pancreas. It has significant role in the evaluation of various pancreatic pathologies
comprising of the congenital, infective, inflammation, neoplastic, traumatic,
and miscellaneous pathologies. This is also important screening tool for differentiating
the indeterminate pancreatic focal lesions like focal pancreatitis versus
neoplastic. MRI using magnetic resonance cholangiopancreatography (MRCP) also evaluates
associated hepatobiliary pancreatic
pathologies. Due to technical advances
in MRI, newer sequences as well as protocols like diffusion-weighted and
T1-weighted dynamic contrast-enhanced MRI are used despite of various challenges of
retroperitoneal location of the Pancreas.
Pancreas is one of the most important organs having both the exocrine and endocrine functions
. MR imaging in pancreas includes the pancreatic and biliary ductal anatomy, detection
and to characterize parenchymal disease, peripancreatic extension and also
associated with the vascular anatomy. Due to the increased technological
advances additional integrated coil elements and also the radiofrequency
channels are applied . 1.5 T MR is being can do 3-dimensional T1-weighted and
MR cholangiopancreatography (MRCP) sequences. The use of the Secretin-enhanced
MRCP (S-MRCP) protocols are able to define the pancreatic ducts and the
parenchymal glandular function also. Evaluation of the suspected
biliopancreatic pain, in the staging of chronic pancreatitis, and diagnosis and
follow-up of pancreatic tumours is more precise now.
To evaluation
of the pancreatic parenchyma and the pancreaticobiliary ductal system are dual-echo
T1- weighted gradient-echo; T2-weighted axial and coronal sequences, turbo spin
echo (TSE) or a variant of TSE; 2-dimensional and 3-dimensional MRCP; and
fat-suppressed T1-weighted, 3- dimensional gradient-echo before and after
gadolinium and the S-MRCP sequence.
The basic T1-weighted sequences for haemorrhage, acute pancreatitis and
identification of the pancreatic fat.
T2-weighted sequences for the evaluation of the
peripancreatic collections and cystic lesions.
Fat suppression
technique has two types for the suppression of the fat. Chemical shift
fat suppression due to the difference of resonance frequency between fat and
water gradient pulses affected by magnetic field inhomogeneity. Another fat
suppression technique is the inversion-recovery (IR) fat suppression, such as
short tau inversion recovery (STIR), having more T1 relaxation times between
fat and water.
MRCP is the commonly used technique for the
acquisition by using the heavily T2- weighted images, with variants of TSE
sequences. The sequences which use the TR and partial Fourier technique are
called SSFSE or half Fourier acquisition single-shot turbo spin echo (HASTE).
Two-dimensional MRCP has traditionally been used with coronal SSFSE slabs and
by using 40-mm slabs in multiple coronal oblique planes which can image the pancreatic ductal system
Three-dimensional MRCP is a 3-dimensional TSE sequence
of very high spatial-resolution . The
use of the thin sections without slice gap can identify the small stones, the small side branches of main
pancreatic duct, and the intrahepatic biliary system. This three-dimensional
MRCP can be acquired in the series of
breath-holds or during free breathing. By using the 1- to 2- mm contiguous slices during free
breathing and by using the
navigator-echo techniques will be reducing motion artifacts.
S-MRCP the concept here is that secretin will cause
distention of the pancreatic ducts and due to this the evaluation of the pancreatic ductal anomalies, anomalous
pancreaticobiliary junction and mild
chronic pancreatitis .
Contrast-Enhanced Sequences is 3-dimensional, fat suppressed, spoiled
gradient echo known by various names like volume interpolated breath-hold
(VIBE), fast gradient echo (F-GRE), liver acquisition with volume acceleration
(LAVA), and T1-weighted, high-resolution, isotropic volume examination
(THRIVE), these sequences are acquired by 2- to 5-mm contiguous slices within a
20-second breath-hold.
PANCREATIC TRAUMA is more commonly presenting as blunt abdominal trauma ranging from 1% to 2%,
pancreatic injuries .Mortality of pancreatic injuries from blunt trauma is 30%, . MR pancreatography can directly imaging of the pancreatic duct as well as
pancreatic parenchyma and peripancreatic fat planes.
Pancreatitis is the commonest of the pancreatic
pathologies and having various causes, Cholelithiasis and alcoholism are the
two most common causes , but other causes also are like autoimmune
pancreatitis, various granulomatous causes are also there. MR can identify the
peripancreatic fat planes , collections, pancreatic ducts and adjacent
peritoneum and mesentery.
The various other diffuse involvement of the pancreas
is also seen in the various inflammatory, infiltrative, or neoplastic
disorders. The inflammatory deposition disorders, including autoimmune
pancreatitis, with the neoplastic
processes include the hemochromatosis,
fatty replacement, and amyloidosis. The infiltrative disorders comprises of the
cystic fibrosis, lymphoma, and metastatic deposition.
Fatty Replacement of the Pancreas Fat replacement,
also termed lipomatosis, adipose atrophy, or fat infiltration of the exocrine
pancreas, is commonly seen in obese and elderly patients. fatty replacement may
be of 3 types: (1) diffuse fatty replacement, which reveals separation of
pancreatic parenchyma with prominence of lobulations; (2) asymmetric fatty
replacement, where a part of pancreas, such as the head region is spared (often
mistaken as tumor); and (3) fatty pseudohypertrophy, where the pancreas is
massively enlarged due to fatty replacement.
Cystic Fibrosis Cystic fibrosis (CF) mainly manifests
as chronic obstructive lung disease and pancreatic exocrine insufficiency, seen
in 85% to 90% of patients
MR imaging T1W MR imaging that shows fat replacement as high signal intensity
and MR imaging directly proportional to the clinical compromise due to exocrine
insufficiency.
MRI and MRCP are routinely used clinically to assess
the pancreas with pancreatic masses, or in those at risk for pancreatic
malignancy. MRCP with higher resolution and breath-hold acquisitions, DWI with
a greater number of b-values and IVIM modelling, and reduced FOV DWI can be assessed
.Acknowledgements
Dr. Bhuchandi References
1. Ma J, Son JB, Zhou Y, et al. Fast spin-echo
tripleecho Dixon (fTED) technique for efficient T2- weighted water and fat
imaging. Magn Reson Med 2007;58:103–9.
2.Bayramoglu S, Kilickesmez O, Cimilli T, et al. T2-
weighted MRI of the upper abdomen: comparison of four fat-suppressed
T2-weighted sequences including PROPELLER (BLADE) technique. Acad Radiol
2010;17(3):368–74. [Epub 2009 Dec 30].
3.Nanko S, Oshima H, Watanabe T, et al. Usefulness of
the application of the BLADE technique to reduce motion artifacts on
navigation-triggered prospective acquisition correction (PACE) T2-weighted MRI
(T2WI) of the liver. J Magn Reson Imaging 2009; 30:321–6.
4.Hirokawa Y, Isoda H, Maetani YS, et al. Evaluation
of motion correction effect and image quality withthe periodically rotated
overlapping parallel lines with enhanced reconstruction (PROPELLER) (BLADE) and
parallel imaging acquisition technique in the upper abdomen. J Magn Reson
Imaging 2008;28:957–62.
5.Purysko AS, Gandhi NS, Walsh RM, Obuchowski NA,
Veniero JC. Does secretin stimulation add to magnetic resonance
cholangiopancreatography in characterising pancreatic cystic lesions as
side-branch intraductal papillary mucinous neoplasm? Eur Radiol
2014;24(12):3134-3141.
6.Canto MI, Harinck F, Hruban RH, et al. International
cancer of the pancreas screening (CAPS) consortium summit on the management of
patients with increased risk for familial pancreatic cancer. Gut
2013;62(3):339-347.
7.Jang KM, Kim SH, Kim YK, Song KD, Lee SJ, Choi D.
Missed pancreatic ductal adenocarcinoma: Assessment of early imaging findings
on prediagnostic magnetic resonance imaging. Eur J Radiol 2015;84(8):1473-1479.
8.Corrias G, Raeside MC, Agostini A, et al. Pilot
study of rapid MR pancreas screening for patients with BRCA mutation. Eur
Radiol 2019;29 (8):3976-3985.
9.Corral JE, Mareth KF, Riegert-Johnson DL, Das A,
Wallace MB. Diagnostic yield from screening asymptomatic individuals at high
risk for pancreatic cancer: A meta-analysis of cohort studies. Clin
Gastroenterol Hepatol 2019;17(1):41-53.
10.Henrikson NB, Aiello Bowles EJ, Blasi PR, et al.
Screening for pancreatic cancer: Updated evidence report and systematic review
for the US preventive services task force. JAMA 2019;322(5):445-454.
11.Schawkat K, Eshmuminov D, Lenggenhager D, Endhardt
K, Vrugt B, Boss A, et al. Preoperative Evaluation of Pancreatic Fibrosis and
Lipomatosis: Correlation of Magnetic Resonance Findings With Histology Using
Magnetization Transfer Imaging and Multigradient Echo Magnetic Resonance
Imaging. Investigative radiology. 2018; 53(12):720–7.